Skip to main content
. 2016 Mar 31;7(26):40846–40859. doi: 10.18632/oncotarget.8519

Table 3. Characteristics of CDK11 interactiving partners.

Interacting Partner Subcellular Localization Cellular Functions Cancer Association References
CHK2 nucleus responses to genotoxic stress mutation or low expression in breast, prostate, ovarian, colon, kidney, thyriod, bladder, lung cancer as well as sarcomas and leukemias 67
CK2 nucleus promotes cell proliferation and growth, suppresses cell apoptosis overexpression or hyperactivation in lung, breast, prostate, gastric, kidney cancer as well as AML, CLL and lymphomas 81; 90
cyclin L1 nucleus regulates transcription and RNA splicing overexpressed in human head and neck cancer, and is associated with lymph node metastases, also amplify in uterine cervical carcinoma and associates with poor prognosis 59; 61; 88
cyclin L2 nucleus functions as a regulator of the pre-mRNA splicing process, modulates the expression of apoptotic and antiapoptotic proteins overexpression of cyclin L2 inhibits cancer cell growth, induces apoptosis and cell cycle arrest, and enhances chemosensitivity 59; 61; 89
cyclin D3 nucleus and cytoplasm forms a complex with CDK4 or CDK6, phosphorylates and inhibits RB protein and regulates the cell cycle G1/S transition overexpressed and associated with a worse prognosis in patients with malignant melanoma, breast cancer, and non-Hodgkin's lymphoma 78
RNPS1 nucleus regulates RNA splicing, promotes mRNA nuclear export and translation, as well as maintenance of postsplicing surveillance overexpressed in mouse submandibular gland adenocarcinoma 60; 65
9G8 nucleus and cytoplasm regulates RNA splicing, promotes nucleocytoplasmic export of mRNA and translate not confirmed 60
ELL2 nucleus promotes transcription initiation and elongation, directs immunoglobulin secretion, inhibits cell growth and survival, induces cell cycle arrest and apoptosis increased expression in leukemia, mutation associated with multiple myeloma and salivary gland carcinoma 45
TFIIF nucleus and cytoplasm promotes transcription elongation by interacting with RNAPII throughout the elongation phase unknown 45
TFIIS nucleus and cytoplasm promotes transcription elongation by enhancing the intrinsic endonucleolytic cleavage activity of RNAPII unknown 45
FACT nucleus modulates nucleosome stability and chromatin remodeling, promotes DNA replication, recombination, and repair, as well as transcript elongation overexpressed in breast carcinoma, non-small-cell lung cancer, renal cell carcinoma, and prostatic, pancreatic, and colorectal adenocarcinomas 45
RBM15B/OTT3 nucleus and cytoplasm inhibits spliceosomal E complex formation, regulates RNA splicing and mRNA export unknown 68
14-3-3 nucleus regulates cell cycle, protein trafficking, and steroidogenesis, promotes cell proliferation, inhibits cell apoptosis overexpressed in breast, lung, liver, head and neck cancers, as well as glioma and astrocytoma 94
Hsp90 cytoplasm and cell membrane maintains normal tissue homeostasis overexpression and/or hyperactivation in almost all human cancers 93
Sufu nucleus and cytoplasm promotes embryonic development deletion, mutation or underexpression in lung, breast, prostate cancer, as well as in medulloblastoma 91; 92